Corvus Pharmaceuticals Ownership & Insider Activity

Corvus Pharmaceuticals (CRVS) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 2.0% of shares outstanding. Institutional investors hold 56.7%.

Shares Outstanding

84.121M

Shares Float

74.006M

Insider Shares Owned

1.700M

Insider % Owned

2.0%

Institutional Shares Held

47.677M

Institutional % Held

56.7%

Ownership Breakdown

Net Insider Activity by Month

Corvus Pharmaceuticals Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Jun 11, 2026	David Scott Moore	—	BUY	21.700K	$11.53	$250K
May 18, 2026	Richard A. Miller	PRESIDENT AND CEO	BUY	6.932K	$12.04	$83K